Panel Discussion: From Molecules to Medicines: How AI Foundation Models are Reshaping Drug Discovery

Name: Panel Discussion: From Molecules to Medicines: How AI Foundation Models are Reshaping Drug Discovery
Start: 2026-11-11T11:05
End: 2026-11-11T11:35
Location: Intercontinental Barcelona

Drug Discovery Chemistry Europe 2026 · 11 November 2026 · 11:05–11:35

Panel Discussion: From Molecules to Medicines: How AI Foundation Models are Reshaping Drug Discovery was a session at Drug Discovery Chemistry Europe 2026 on 11 November 2026 in Barcelona, with 7 speakers on record.

Speakers

Ashwini Ghogare — Moderator GenAI Leader for Start-ups, Life Sciences and Healthcare, Amazon Web Services
Steven Crossan — Panelist CEO & Founder, Dayhoff Labs
Lindsay Edwards — Panelist CTO, Relation Therapeutics Ltd.
Fanny Jaulin — Panelist CEO & Cofounder, Orakl Oncology
Iva Lukac — Panelist Director of AI in Drug Discovery, Apheris
Jeremy Wohlwend — Panelist CTO, Boltz
Gustave Ronteix — Panelist Co-Founder and CTO, Orakl Oncology